Driving Automation for Older Adults with Preclinical Alzheimer’s Disease
Gerontology · 2023
DOI: 10.1159/000531263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gerontology, 2023. Verfasst von Pedram Ahmadnezhad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, Rehabilitation Science, and Athletic Training, University of Kansas Medical Center, Kansas City, Kansas, USA, pedram_…. Hauptthemen laut MEDLINE: Alzheimer Disease, Automobile Driving. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCRR NIH HHS.
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
Introduction
Older adults with preclinical Alzheimer’s disease (AD) show changes in on-road driving performance. The impact of preclinical AD on using automated vehicle (AV) technology is unknown. The aim was to evaluate safety and cognitive workload while operating AV technology in drivers with preclinical AD.
Introduction
This cross-sectional study included 40 participants: 19 older adults (age 74.16 ± 4.78; MOCA scores 26.42 ± 2.52) with preclinical AD, evidenced by elevated cortical beta-amyloid; and 21 controls (age 73.81 ± 5.62; MOCA scores 28.24 ± 1.67). All participants completed two scenarios in a driving simulator. Scenario 1 included conditional automation with an emergency event that required a manual take-over maneuver. Scenario 2 was identical but with a cognitive distractor task. Emergency response time was the main safety outcome measure. Cognitive workload was calculated using moment-to-moment changes in pupillary size and converted into an Index of Cognitive Activity (ICA). Mann-Whitney U and independent t tests were used to compare group differences.
Results
Emergency response times were similar between drivers with preclinical AD and controls in scenario 1 (20.85 s ± 1.08 vs. 20.52 s ± 3.18; p = 0.83) and scenario 2 (14.83 s ± 7.37 vs. 13.45 s ± 10.43; p = 0.92). Likewise, no differences were found in ICA between drivers with preclinical AD and controls in scenario 1 (0.34 ± 0.08 vs. 0.33 ± 0.17; p = 0.74) or scenario 2 (0.30 ± 0.07 vs. 0.29 ± 0.17; p = 0.93).
Conclusions
Older drivers with preclinical AD may safely operate AV technology, without increased response times or cognitive workload. Future on-road studies with AV technology should confirm these preliminary results in drivers with preclinical AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Therapy, Rehabilitation Science, and Athletic Training, University of Kansas Medical Center, Kansas City, Kansas, USA, pedram_a68@yahoo.com.
- University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Physical Therapy, Rehabilitation Science, and Athletic Training, University of Kansas Medical Center, Kansas City, Kansas, USA.
- University of Kansas Center for Community Access, Rehabilitation Research, Education, and Service (KU-CARES), University of Kansas Medical Center, Kansas City, Kansas, USA.
- Université Gustave Eiffel, IFSTTAR, University Lyon, Lyon, France.
Förderung
- NIA NIH HHS
- NCRR NIH HHS
Zitieren
APA
Ahmadnezhad, P., Burns, J. M., Akinwuntan, A. E., Ranchet, M., Kondyli, A., Mahnken, J. D., & Devos, H. (2023). Driving Automation for Older Adults with Preclinical Alzheimer’s Disease. Gerontology. https://doi.org/10.1159/000531263
Vancouver
Ahmadnezhad P, Burns JM, Akinwuntan AE, Ranchet M, Kondyli A, Mahnken JD, et al. Driving Automation for Older Adults with Preclinical Alzheimer’s Disease. Gerontology. 2023. doi:10.1159/000531263
BibTeX
@article{Ahmadnezhad2023,
author = {Ahmadnezhad, Pedram and Burns, Jeffrey M and Akinwuntan, Abiodun E and Ranchet, Maud and Kondyli, Alexandra and Mahnken, Jonathan D and Devos, Hannes},
title = {Driving Automation for Older Adults with Preclinical Alzheimer’s Disease},
journal = {Gerontology},
year = {2023},
doi = {10.1159/000531263}
}
EUVIMED